Skip Nav Destination
Issues
1 March 2021
-
Cover Image
Cover Image
The cover shows a section of an invasive breast carcinoma with RET amplification. RET structural variant was not detected. RET immunohistochemistry shows a heterogenous staining pattern. For details, see the article by Yang and colleagues on page 1316 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR Drug Updates
FDA Approval Summary: Tucatinib for the Treatment of Patients with Advanced or Metastatic HER2-positive Breast Cancer
Mirat Shah; Suparna Wedam; Joyce Cheng; Mallorie H. Fiero; Huiming Xia; Fang Li; Jianghong Fan; Xinyuan Zhang; Jingyu Yu; Pengfei Song; Wei Chen; Tiffany K. Ricks; Xiao Hong Chen; Kirsten B. Goldberg; Yutao Gong; William F. Pierce; Shenghui Tang; Marc R. Theoret; Richard Pazdur; Laleh Amiri-Kordestani; Julia A. Beaver
Review
Perspectives
Clinical Trial Brief Report
Eradication of T-ALL Cells by CD7-targeted Universal CAR-T Cells and Initial Test of Ruxolitinib-based CRS Management
Shiqi Li; Xinxin Wang; Zhongtao Yuan; Lin Liu; Le Luo; Yu Li; Kun Wu; Jia Liu; Chunhui Yang; Zhimin Li; Duanpeng Wang; Lianjun Shen; Xun Ye; Jiaping He; Cong Han; Youcheng Wang; Dingsong Zhang; Yancheng Dong; Lihua Fang; Yingnian Chen; Martina Sersch; Wei William Cao; Sanbin Wang
Clinical Trials: Targeted Therapy
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor−positive Metastatic Breast Cancer or Other Solid Tumors
Alexej Ballhausen; Jennifer J. Wheler; Daniel D. Karp; Sarina A. Piha-Paul; Siqing Fu; Shubham Pant; Apostolia M. Tsimberidou; David S. Hong; Vivek Subbiah; Veronica R. Holley; Helen J. Huang; Abenaa M. Brewster; Kimberly B. Koenig; Nuhad K. Ibrahim; Funda Meric-Bernstam; Filip Janku
Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
Rosemarie de Haan; Michel M. van den Heuvel; Judi van Diessen; Heike M.U. Peulen; Erik van Werkhoven; Adrianus J. de Langen; Ferry Lalezari; Dick Pluim; Manon Verwijs-Janssen; Conchita Vens; Jan H.M. Schellens; Neeltje Steeghs; Marcel Verheij; Baukelien van Triest
Clinical Trials: Immunotherapy
Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial
Amita Patnaik; Timothy A. Yap; Hyun Cheol Chung; Maria J. de Miguel; Yung-Jue Bang; Chia-Chi Lin; Wu-Chou Su; Antoine Italiano; Kay Hoong Chow; Anna M. Szpurka; Danni Yu; Yumin Zhao; Michelle Carlsen; Shelly Schmidt; Burkhard Vangerow; Leena Gandhi; Xiaojian Xu; Johanna Bendell
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma
Lei Zheng; Ding Ding; Barish H. Edil; Carol Judkins; Jennifer N. Durham; Dwayne L. Thomas, II; Katherine M. Bever; Guanglan Mo; Sara E. Solt; Jessica A. Hoare; Raka Bhattacharya; Qingfeng Zhu; Arsen Osipov; Beth Onner; Katrina A. Purtell; Hongyan Cai; Rose Parkinson; Amy Hacker-Prietz; Joseph M. Herman; Dung T. Le; Nilofer S. Azad; Ana M.C. De Jesus-Acosta; Alex B. Blair; Victoria Kim; Kevin C. Soares; Lindsey Manos; John L. Cameron; Martin A. Makary; Matthew J. Weiss; Richard D. Schulick; Jin He; Christopher L. Wolfgang; Elizabeth D. Thompson; Robert A. Anders; Elizabeth Sugar; Elizabeth M. Jaffee; Daniel A. Laheru
Ipilimumab and Radiation in Patients with High-risk Resected or Regionally Advanced Melanoma
April K.S. Salama; Manisha Palta; Christel N. Rushing; M. Angelica Selim; Kristen N. Linney; Brian G. Czito; David S. Yoo; Brent A. Hanks; Georgia M. Beasley; Paul J. Mosca; Chelsae Dumbauld; Katelyn N. Steadman; John S. Yi; Kent J. Weinhold; Douglas S. Tyler; Walter T. Lee; David M. Brizel
Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy
Caicun Zhou; Yina Wang; Jun Zhao; Gongyan Chen; Zhihua Liu; Kangsheng Gu; Meijuan Huang; Jianxing He; Jianhua Chen; Zhiyong Ma; Jifeng Feng; Jianhua Shi; Xinmin Yu; Ying Cheng; Yu Yao; Yuan Chen; Renhua Guo; Xiaoyan Lin; Zhehai Wang; Guanghui Gao; Quanren Wang; Weixia Li; Xinfeng Yang; Lihong Wu; Jun Zhang; Shengxiang Ren
Precision Medicine and Imaging
Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET
Sinan Wang; Jun Li; Jun Hua; Yang Su; Denis R. Beckford-Vera; Walter Zhao; Mayuri Jayaraman; Tony L. Huynh; Ning Zhao; Yung-hua Wang; Yangjie Huang; Fujun Qin; Sui Shen; Daniel Gioeli; Robert Dreicer; Renuka Sriram; Emily A. Egusa; Jonathan Chou; Felix Y. Feng; Rahul Aggarwal; Michael J. Evans; Youngho Seo; Bin Liu; Robert R. Flavell; Jiang He
A Performance Comparison of Commonly Used Assays to Detect RET Fusions
Soo-Ryum Yang; Umut Aypar; Ezra Y. Rosen; Douglas A. Mata; Ryma Benayed; Kerry Mullaney; Gowtham Jayakumaran; Yanming Zhang; Denise Frosina; Alexander Drilon; Marc Ladanyi; Achim A. Jungbluth; Natasha Rekhtman; Jaclyn F. Hechtman
Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
Yuxi Yi; Lijun Shen; Wei Shi; Fan Xia; Hui Zhang; Yan Wang; Jing Zhang; Yaqi Wang; Xiaoyang Sun; Zhiyuan Zhang; Wei Zou; Wang Yang; Lingyi Zhang; Ji Zhu; Ajay Goel; Yanlei Ma; Zhen Zhang
Final Results of the Prospective Biomarker Trial PETra: [11C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
Annekatrin Seidlitz; Bettina Beuthien-Baumann; Steffen Löck; Christina Jentsch; Ivan Platzek; Klaus Zöphel; Annett Linge; Jörg Kotzerke; Jan Petr; Jörg van den Hoff; Jörg Steinbach; Dietmar Krex; Gabriele Schmitz-Schackert; Monique Falk; Michael Baumann; Mechthild Krause
Author Choice
The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer
Saya Jacob; Andrew A. Davis; Lorenzo Gerratana; Marko Velimirovic; Ami N. Shah; Firas Wehbe; Neelima Katam; Qiang Zhang; Lisa Flaum; Kalliopi P. Siziopikou; Leonidas C. Platanias; William J. Gradishar; Amir Behdad; Aditya Bardia; Massimo Cristofanilli
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma
Miriam Ficial; Opeyemi A. Jegede; Miriam Sant'Angelo; Yue Hou; Abdallah Flaifel; Jean-Christophe Pignon; David A. Braun; Megan Wind-Rotolo; Maura A. Sticco-Ivins; Paul J. Catalano; Gordon J. Freeman; Arlene H. Sharpe; F. Stephen Hodi; Robert J. Motzer; Catherine J. Wu; Michael B. Atkins; David F. McDermott; Sachet A. Shukla; Toni K. Choueiri; Sabina Signoretti
CamGFR v2: A New Model for Estimating the Glomerular Filtration Rate from Standardized or Non-standardized Creatinine in Patients with Cancer
Edward H. Williams; Thomas R. Flint; Claire M. Connell; Daniel Giglio; Hassal Lee; Taehoon Ha; Eva Gablenz; Nicholas J. Bird; James M.J. Weaver; Harry Potts; Cameron T. Whitley; Michael A. Bookman; Andy G. Lynch; Hannah V. Meyer; Simon Tavaré; Tobias Janowitz
Author Choice
Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer
Heather J. Chalfin; Tiziano Pramparo; Amir Mortazavi; Scot A. Niglio; Joseph D. Schonhoft; Adam Jendrisak; Yen-Lin Chu; Robin Richardson; Rachel Krupa; Amanda K.L. Anderson; Yipeng Wang; Ryan Dittamore; Sumanta K. Pal; Primo N. Lara; Mark N. Stein; David I. Quinn; Seth M. Steinberg; Lisa M. Cordes; Lisa Ley; Marissa Mallek; Olena Sierra Ortiz; Rene Costello; Jacqueline Cadena; Carlos Diaz; James L. Gulley; William L. Dahut; Howard Streicher; John J. Wright; Jane B. Trepel; Donald P. Bottaro; Andrea B. Apolo
Author Choice
177Lu-DOTA-EB-TATE, a Radiolabeled Analogue of Somatostatin Receptor Type 2, for the Imaging and Treatment of Thyroid Cancer
Shilpa Thakur; Brianna Daley; Corina Millo; Craig Cochran; Orit Jacobson; Huiyan Lu; Zhantong Wang; Dale Kiesewetter; Xiaoyuan Chen; Vasyl Vasko; Joanna Klubo-Gwiezdzinska
Translational Cancer Mechanisms and Therapy
Author Choice
Proteasome Inhibition Overcomes ALK-TKI Resistance in ALK-Rearranged/TP53-Mutant NSCLC via Noxa Expression
Azusa Tanimoto; Shingo Matsumoto; Shinji Takeuchi; Sachiko Arai; Koji Fukuda; Akihiro Nishiyama; Kiyotaka Yoh; Takaya Ikeda; Naoki Furuya; Kazumi Nishino; Yuichiro Ohe; Koichi Goto; Seiji Yano
Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women
Lindsay J. Collin; Deirdre P. Cronin-Fenton; Thomas P. Ahern; Michael Goodman; Lauren E. McCullough; Lance A. Waller; Anders Kjærsgaard; Per Damkier; Peer M. Christiansen; Bent Ejlertsen; Maj-Britt Jensen; Henrik Toft Sørensen; Timothy L. Lash
Characterization and Clinical Outcomes of DNA Mismatch Repair–deficient Small Bowel Adenocarcinoma
Alicia Latham; Jinru Shia; Zalak Patel; Diane L. Reidy-Lagunes; Neil H. Segal; Rona Yaeger; Karuna Ganesh; Louise Connell; Nancy E. Kemeny; David P. Kelsen; Jaclyn F. Hechtman; Garrett M. Nash; Philip B. Paty; Ahmet Zehir; Kaitlin A. Tkachuk; Rania Sheikh; Arnold J. Markowitz; Diana Mandelker; Kenneth Offit; Michael F. Berger; Andrea Cercek; Julio Garcia-Aguilar; Leonard B. Saltz; Martin R. Weiser; Zsofia K. Stadler
Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen; Christopher Nelson; Matthew Wong; Andrew E. Tee; Pei Y. Liu; Ting La; Jamie I. Fletcher; Alvin Kamili; Chelsea Mayoh; Christoph Bartenhagen; Toby N. Trahair; Ning Xu; Nisitha Jayatilleke; Marie Wong; Hui Peng; Bernard Atmadibrata; Belamy B. Cheung; Qing Lan; Tracy M. Bryan; Pieter Mestdagh; Jo Vandesompele; Valerie Combaret; Valentina Boeva; Jenny Y. Wang; Isabelle Janoueix-Lerosey; Mark J. Cowley; Karen L. MacKenzie; Alla Dolnikov; Jinyan Li; Patsie Polly; Glenn M. Marshall; Roger R. Reddel; Murray D. Norris; Michelle Haber; Matthias Fischer; Xu D. Zhang; Hilda A. Pickett; Tao Liu
Author Choice
Preclinical Characterization of HPN536, a Trispecific, T-Cell–Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors
Mary Ellen Molloy; Richard J. Austin; Bryan D. Lemon; Wade H. Aaron; Vaishnavi Ganti; Adrie Jones; Susan D. Jones; Kathryn L. Strobel; Purbasa Patnaik; Kenneth Sexton; Laurie Tatalick; Timothy Z. Yu; Patrick A. Baeuerle; Che-Leung Law; Holger Wesche
Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma
Tyler D. Hitchman; Gabriella Bayshtok; Emilie Ceraudo; Amanda R. Moore; Cindy Lee; Ruobing Jia; Naitao Wang; Mohini R. Pachai; Alexander N. Shoushtari; Jasmine H. Francis; Youxin Guan; Juliet Chen; Matthew T. Chang; Barry S. Taylor; Thomas P. Sakmar; Thomas Huber; Ping Chi; Yu Chen
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma
Adrià Bernat-Peguera; Juan Navarro-Ventura; Laura Lorenzo-Sanz; Victoria da Silva-Diz; Mattia Bosio; Luis Palomero; Rosa M. Penin; Diana Pérez Sidelnikova; Josep Oriol Bermejo; Miren Taberna; Noelia Vilariño; Josep M. Piulats; Ricard Mesia; Joan Maria Viñals; Eva González-Suárez; Salvador Capella-Gutierrez; Alberto Villanueva; Francesc Viñals; Purificación Muñoz
The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas
Alvin P. Makohon-Moore; Evan J. Lipson; Jody E. Hooper; Amanda Zucker; Jungeui Hong; Craig M. Bielski; Akimasa Hayashi; Collin Tokheim; Priscilla Baez; Rajya Kappagantula; Zachary Kohutek; Vladimir Makarov; Nadeem Riaz; Michael A. Postow; Paul B. Chapman; Rachel Karchin; Nicholas D. Socci; David B. Solit; Timothy A. Chan; Barry S. Taylor; Suzanne L. Topalian; Christine A. Iacobuzio-Donahue
Author Choice
AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer
Michael J. Giffin; Keegan Cooke; Edward K. Lobenhofer; Juan Estrada; Jinghui Zhan; Petra Deegen; Melissa Thomas; Christopher M. Murawsky; Jonathan Werner; Siyuan Liu; Fei Lee; Oliver Homann; Matthias Friedrich; Joshua T. Pearson; Tobias Raum; Yajing Yang; Sean Caenepeel; Jennitte Stevens; Pedro J. Beltran; Jude Canon; Angela Coxon; Julie M. Bailis; Paul E. Hughes
Author Choice
CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma
Deepak Raj; Maria Nikolaidi; Irene Garces; Daniela Lorizio; Natalia M. Castro; Sabrina G. Caiafa; Kate Moore; Nicholas F. Brown; Hemant M. Kocher; Xiaobo Duan; Brad H. Nelson; Nicholas R. Lemoine; John F. Marshall
The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers
Zhiyuan Hu; Paula Cunnea; Zhe Zhong; Haonan Lu; Oloruntoba I. Osagie; Leticia Campo; Mara Artibani; Katherine Nixon; Jennifer Ploski; Laura Santana Gonzalez; Abdulkhaliq Alsaadi; Nina Wietek; Stephen Damato; Sunanda Dhar; Sarah P. Blagden; Christopher Yau; Joanna Hester; Ashwag Albukhari; Eric O. Aboagye; Christina Fotopoulou; Ahmed Ahmed
Letters to the Editor
Correction
Correction: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–positive Breast Cancer
Sara M. Tolaney; Solmaz Sahebjam; Emilie Le Rhun; Thomas Bachelot; Peter Kabos; Ahmad Awada; Denise Yardley; Arlene Chan; Pierfranco Conte; Véronique Diéras; Nancy U. Lin; Melissa Bear; Sonya C. Chapman; Zhengyu Yang; Yanyun Chen; Carey K. Anders
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.